Oncology Institute/the Share Price (NASDAQ: TOI)

$3.4

▲

-0.08

(-2.3%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Oncology Institute/the Stock chart to analyse performance

Oncology Institute/the stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$3.32
Today's High:$3.52
$3.40
2.35%
Downside
Day's Volatility :5.55%
Upside
3.27%
52 Weeks Low:$0.13
52 Weeks High:$4.50
$3.40
96.31%
Downside
52 Weeks Volatility :97.22%
Upside
24.44%

Oncology Institute/the Stock Returns

Period	Oncology Institute Inc/the	Sector (Health Care)	Index (Russel 2000)
3 Months	4.77%	3.6%	0.0%
6 Months	370.3%	-7.7%	0.0%
1 Year	844.78%	-12.6%	0.0%
3 Years	-44.63%	9.5%	-4.7%

Oncology Institute Inc/the Key Stats

Check Oncology Institute/the key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$3.48
Open	$3.49
Today's High	$3.515
Today's Low	$3.32
Market Capitalization	$325.4M
Today's Volume	$1.6M
52 Week High	$4.5
52 Week Low	$0.1253
Revenue TTM	$424.4M
EBITDA	$-40.0M
Earnings Per Share (EPS)	$-0.67
Profit Margin	-15.53%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-651.69%

Stock Returns calculator for Oncology Institute/the Stock including INR - Dollar returns

The Oncology Institute/the stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Oncology Institute/the investment value today

Current value as on today

₹9,49,729

Returns

₹8,49,729

(+849.73%)

Returns from Oncology Institute/the Stock

₹8,44,444 (+844.44%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Oncology Institute/the Stock

33%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Oncology Institute/the Stock from India on INDmoney has increased by 33% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Oncology Institute Inc/the

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
4.59%
TIFF Advisory Services Inc
3.90%
Deerfield Management Co
3.60%
Balyasny Asset Management LLC
2.30%
Marshall Wace Asset Management Ltd
1.58%
Wexford Capital LP
1.20%

Analyst Recommendation on Oncology Institute/the Stock

Rating

Trend

Buy

80%Buy

20%Hold

0%Sell

Based on 5 Wall street analysts offering stock ratings for Oncology Institute/the(by analysts ranked 0 to 5 stars)

Oncology Institute/the Share Price Target

What analysts predicted

Upside of 105.88%

Target:

$7.00

Current:

$3.40

Oncology Institute/the share price target is $7.00, a slight Upside of 105.88% compared to current price of $3.40 as per analysts' prediction.

Oncology Institute/the Stock Insights

Price Movement
In the last 1 year, TOI stock has moved up by 843.7%
Increasing Revenue
Revenue is up for the last 18 quarters, 48.58M → 119.80M (in $), with an average increase of 5.1% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -19.58M → -17.00M (in $), with an average increase of 15.1% per quarter
TOI vs THC (3 yr)
In the last 3 years, Tenet Healthcare Corp. has given 50.6% return, outperforming this stock by 95.9%

Oncology Institute Inc/the Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$155.4M	↑ 37.33%
Net Income	$-4.0M	↓ 201.86%
Net Profit Margin	-2.59%	↓ 6.08%

	FY20	Y/Y Change
Revenue	$187.5M	↑ 20.66%
Net Income	$-14.3M	↑ 256.13%
Net Profit Margin	-7.64%	↓ 5.05%

	FY21	Y/Y Change
Revenue	$203.0M	↑ 8.26%
Net Income	$-10.9M	↓ 23.7%
Net Profit Margin	-5.38%	↑ 2.26%

	FY22	Y/Y Change
Revenue	$252.5M	↑ 24.37%
Net Income	$152.0K	↓ 101.39%
Net Profit Margin	0.06%	↑ 5.44%

	FY23	Y/Y Change
Revenue	$324.2M	↑ 28.42%
Net Income	$-83.1M	↓ 54750.0%
Net Profit Margin	-25.62%	↓ 25.68%

	FY24	Y/Y Change
Revenue	$393.4M	↑ 21.33%
Net Income	$-64.7M	↓ 22.16%
Net Profit Margin	-16.44%	↑ 9.18%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$94.7M	↑ 10.35%
Net Income	$-19.9M	↑ 6.05%
Net Profit Margin	-21.01%	↑ 0.85%

	Q2 FY24	Q/Q Change
Revenue	$98.6M	↑ 4.13%
Net Income	$-15.5M	↓ 22.17%
Net Profit Margin	-15.7%	↑ 5.31%

	Q3 FY24	Q/Q Change
Revenue	$99.9M	↑ 1.34%
Net Income	$-16.1M	↑ 4.1%
Net Profit Margin	-16.13%	↓ 0.43%

	Q4 FY24	Q/Q Change
Revenue	$100.3M	↑ 0.37%
Net Income	$-13.2M	↓ 18.19%
Net Profit Margin	-13.15%	↑ 2.98%

	Q1 FY25	Q/Q Change
Revenue	$104.4M	↑ 4.13%
Net Income	$-19.6M	↑ 48.57%
Net Profit Margin	-18.76%	↓ 5.61%

	Q2 FY25	Q/Q Change
Revenue	$119.8M	↑ 14.75%
Net Income	$-17.0M	↓ 13.15%
Net Profit Margin	-14.2%	↑ 4.56%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$29.9M	↑ 13.92%

	FY20	Y/Y Change
Profit	$36.9M	↑ 23.17%

	FY21	Y/Y Change
Profit	$40.8M	↑ 10.76%

	FY22	Y/Y Change
Profit	$52.1M	↑ 27.53%

	FY23	Y/Y Change
Profit	$59.6M	↑ 14.36%

	FY24	Y/Y Change
Profit	$54.0M	↓ 9.36%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$12.0M	↓ 16.76%

	Q2 FY24	Q/Q Change
Profit	$13.0M	↑ 8.83%

	Q3 FY24	Q/Q Change
Profit	$14.4M	↑ 10.29%

	Q4 FY24	Q/Q Change
Profit	$14.6M	↑ 1.88%

	Q1 FY25	Q/Q Change
Profit	$17.2M	↑ 17.85%

	Q2 FY25	Q/Q Change
Profit	$15.7M	↓ 9.0%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$3.6M	↓ 35.92%
Investing Cash Flow	$-1.2M	↓ 148.4%
Financing Cash Flow	$-1.8K	↓ 99.98%

	FY20	Y/Y Change
Operating Cash Flow	$508.2K	↓ 85.94%
Investing Cash Flow	$-8.8M	↑ 634.22%
Financing Cash Flow	$11.9M	↓ 655447.3%

	FY21	Y/Y Change
Operating Cash Flow	$-32.7M	↓ 6530.05%
Investing Cash Flow	$-12.2M	↑ 37.42%
Financing Cash Flow	$154.0M	↑ 1195.51%

	FY22	Y/Y Change
Operating Cash Flow	$-61.8M	↑ 88.97%
Investing Cash Flow	$-131.6M	↑ 982.89%
Financing Cash Flow	$92.2M	↓ 40.13%

	FY23	Y/Y Change
Operating Cash Flow	$-36.3M	↓ 41.2%
Investing Cash Flow	$62.6M	↓ 147.59%
Financing Cash Flow	$-6.8M	↓ 107.43%

	FY24	Y/Y Change
Operating Cash Flow	$-26.5M	↓ 26.92%
Investing Cash Flow	$46.2M	↓ 26.23%
Financing Cash Flow	$-3.5M	↓ 49.0%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-15.9M	↑ 307.99%
Investing Cash Flow	$19.4M	↑ 66.75%
Financing Cash Flow	$-938.0K	↓ 47.33%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-15.7M	↓ 1.4%
Investing Cash Flow	$18.2M	↓ 6.25%
Financing Cash Flow	$-2.1M	↑ 128.89%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$819.0K	↓ 105.23%
Investing Cash Flow	$10.4M	↓ 42.77%
Financing Cash Flow	$-243.0K	↓ 88.68%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$4.2M	↑ 411.11%
Investing Cash Flow	$-1.8M	↓ 116.87%
Financing Cash Flow	$-164.0K	↓ 32.51%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-5.0M	↓ 219.16%
Investing Cash Flow	$-202.0K	↓ 88.49%
Financing Cash Flow	$-4.7M	↑ 2790.24%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-10.2M	↑ 104.53%
Investing Cash Flow	$-1.2M	↑ 498.02%
Financing Cash Flow	$2.0M	↓ 141.41%

Oncology Institute/the Technicals Summary

Sell

Neutral

Buy

Oncology Institute/the is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Oncology Institute Inc/the Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Oncology Institute Inc/the	-7.22%	370.3%	844.78%	-44.63%	-66.29%
Fresenius Medical Care Ag	2.27%	9.13%	33.85%	52.16%	-38.9%
Hca Holdings, Inc.	13.07%	29.66%	1.97%	102.37%	200.76%
Encompass Health Corporation	12.13%	21.96%	30.5%	149.95%	85.63%
Universal Health Services Inc.	11.44%	3.32%	-23.19%	86.77%	64.27%
Tenet Healthcare Corp.	16.59%	47.97%	14.02%	226.96%	548.52%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Oncology Institute Inc/the	47.33	NA	NA	-0.55	-6.52	-0.17	NA	-0.1
Fresenius Medical Care Ag	19.34	19.34	0.42	1.96	0.06	0.03	0.03	45.23
Hca Holdings, Inc.	16.98	16.98	1.32	26.34	1.36	0.12	0.01	-18.61
Encompass Health Corporation	23.73	23.73	NA	5.28	0.25	0.09	0.01	22.6
Universal Health Services Inc.	9.57	9.57	1.87	20.44	0.19	0.08	0.0	110.47
Tenet Healthcare Corp.	11.59	11.59	0.85	15.81	0.3	0.08	NA	42.44

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Oncology Institute Inc/the	Buy	$325.4M	-66.29%	47.33	-15.53%
Fresenius Medical Care Ag	Hold	$14.8B	-38.9%	19.34	3.36%
Hca Holdings, Inc.	Buy	$95.3B	200.76%	16.98	8.21%
Encompass Health Corporation	Buy	$12.4B	85.63%	23.73	9.22%
Universal Health Services Inc.	Hold	$11.6B	64.27%	9.57	7.66%
Tenet Healthcare Corp.	Buy	$16.3B	548.52%	11.59	7.18%

About Oncology Institute Inc/the

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance services. The company also provides and manages clinical trials, palliative care programs, stem cell transplants services, other care delivery models associated with non-community-based academic, and tertiary care settings; and conducts clinical trials for a range of pharmaceutical, and medical device companies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Organization	Oncology Institute/the
Employees	825
CEO	Dr. Daniel Virnich FACHE, M.B.A., M.D.
Industry	Financial

Key Management of Oncology Institute Inc/the

Name	Title
Dr. Daniel Virnich FACHE, M.B.A., M.D.	CEO & Executive Director
Dr. Yale D. Podnos F.A.C.S., M.D., M.P.H.	Chief Medical Officer
Mr. Robert Carter	Chief Financial Officer
Mr. Austin Lee	VP of Accounting & Controller
Ms. Kristin England	Chief Administrative Officer
Mr. Mark Hueppelsheuser Esq.	General Counsel
Mr. Jordan McInerney	Chief Development Officer
Mr. Stephen Cella	Senior Vice President of Finance
Dr. Jeffrey Langsam M.D.	Chief Clinical Officer

Important FAQs about investing in TOI Stock from India :

What is Oncology Institute/the share price today?

Oncology Institute/the share price today is $3.40 as on August 30, 2025 at 1:29 am IST at the close of the market. Oncology Institute/the share today touched a day high of $3.52 and a low of $3.32.

What is the 52 week high and 52 week low for Oncology Institute/the share?

Oncology Institute/the share touched a 52 week high of $4.50 and a 52 week low of $0.13. Oncology Institute/the stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $3.40, lower by 24.44% versus the 52 week high.

How to invest in Oncology Institute/the Stock (TOI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Oncology Institute/the on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Oncology Institute/the Shares that will get you 0.4412 shares as per Oncology Institute/the share price of $3.40 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Oncology Institute/the Stock (TOI) from India?

Indian investors can start investing in Oncology Institute/the (TOI) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Oncology Institute/the stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Oncology Institute/the share’s latest price of $3.40 as on August 30, 2025 at 1:29 am IST, you will get 2.9412 shares of Oncology Institute/the. Learn more about fractional shares .

What are the returns that Oncology Institute/the has given to Indian investors in the last 5 years?

Oncology Institute/the stock has given -66.29% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?